Clinical Convergence® Patient & Provider Perspectives in IBD

December 7, 2019

 

Optimizing Clinical Outcomes in Blood Cancers Through Groundbreaking Translational Research
CLINICAL CONVERGENCE®
PATIENT & PROVIDER
PERSPECTIVES IN IBD
Join us in Indianapolis
Saturday,
December 7, 2019
8:30 AM – 12:00 PM
IBD patients and their caregivers are invited to learn
from leading IBD experts and experienced IBD patients!

If you're an IBD healthcare professional, EARN UP TO 3.0 AMA PRA CATEGORY 1 CREDIT(S)™, 3.0 ANCC CONTACT HOUR(S), AND ABIM MOC CREDIT!
 
     
 

PATIENT & CAREGIVER AGENDA

8:30 AM – 9:00 AM Registration and Breakfast
9:00 AM – 9:15 AM Welcome and Overview of Educational Goals
  Monika Fischer, MD, MS, FACG, AGAF
9:15 AM – 10:00 AM Workshop:
Shared Decision Making and Patient Tools:
A Guide to Participating in Your Care
  Monika Fischer, MD, MS, FACG, AGAF
10:00 AM – 10:15 AM Break
10:15 AM – 10:35 AM Medication and Patient Monitoring
  Matthew E. Bohm, DO
10:35 AM – 11:00 AM Making Treatment Decisions
  Sashidhar Sagi, MBBS
11:00 AM – 11:15 AM Break
11:15 AM – 11:50 AM Clinical Convergence® Session and Panel Discussion
11:50 AM – 12:00 PM Closing Remarks and Call to Action

HEALTHCARE PROFESSIONAL AGENDA

8:00 AM – 8:30 AM Registration and Breakfast
8:30 AM – 8:50 AM Welcome and Updates in IBD
  Monika Fischer, MDMS, FACG, AGAF and
Stephen B. Hanauer, MD
8:50 AM – 9:20 AM Monitoring in IBD:
Guiding Treatment Decision Making
  Matthew E. Bohm, DO
9:20 AM – 9:35 AM Break
9:35 AM – 10:15 AM Individualized Therapy for Optimal Patient Outcomes
  Sashidhar Sagi, MBBS
10:15 AM – 11:00 AM Health Maintenance in IBD and Shared Decision Making
  Monika Fischer, MD, MS, FACG, AGAF
11:00 AM – 11:15 AM Break
11:15 AM – 11:50 AM Clinical Convergence® Session with Patients and Caregivers
11:50 AM – 12:00 PM Closing Remarks
 
 
     

Jointly provided by the Indiana University School of Medicine, the Crohn's & Colitis Foundation, and RMEI Medical Education, LLC. 

 

This activity is supported by educational grants from Takeda Pharmaceuticals USA, Inc., Janssen Biotech, Inc., administered by Janssen Scietific Affairs, LLC, Celgene Corporation, and Salix, a division of Bausch Health US, LLC. This activity is supported by a contribution from Lilly.

 

© Copyright 2019. All rights reserved. Managed by the Crohn's & Colitis Foundation.
733 Third Avenue, Suite 510 | New York, NY 10017 | www.crohnscolitisfoundation.org | 800-932-2423

This email is developed by RMEI Medical Education, LLC, a full-service medical education company.